Erratum: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis (Breast Cancer Research (2020) 22:16 DOI: 10.1186/s13058-020-1246-5)

Adi Zundelevich; Maya Dadiani; Smadar Kahana-Edwin; Amit Itay; Tal Sella; Moran Gadot; Karen Cesarkas; Sarit Farage-Barhom; Efrat Glick Saar; Eran Eyal; Nitzan Kol; Anya Pavlovski; Nora Balint-Lahat; Daniela Dick-Necula; Iris Barshack; Bella Kaufman; Einav Nili Gal-Yam

doi:10.1186/s13058-020-01265-y

Erratum: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis (Breast Cancer Research (2020) 22:16 DOI: 10.1186/s13058-020-1246-5)

Adi Zundelevich, Maya Dadiani, Smadar Kahana-Edwin, Amit Itay, Tal Sella, Moran Gadot, Karen Cesarkas, Sarit Farage-Barhom, Efrat Glick Saar, Eran Eyal, Nitzan Kol, Anya Pavlovski, Nora Balint-Lahat, Daniela Dick-Necula, Iris Barshack, Bella Kaufman, Einav Nili Gal-Yam^*

^*Corresponding author for this work

Sheba Medical Center at Tel Hashomer

Research output: Contribution to journal › Comment/debate

3 Scopus citations

Abstract

After the publication of the original article [1], we were notified the upper panel of the Fig. 1, where the patients codes are listed, was cropped by mistake so the patients 1-8 are repeated. The 88 patients should be listed, instead. Below is the correct version of Fig. 1.

Original language	English
Article number	28
Journal	Breast Cancer Research
Volume	22
Issue number	1
DOIs	https://doi.org/10.1186/s13058-020-01265-y
State	Published - 12 Mar 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1186/s13058-020-01265-y

Fingerprint

Dive into the research topics of 'Erratum: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis (Breast Cancer Research (2020) 22:16 DOI: 10.1186/s13058-020-1246-5)'. Together they form a unique fingerprint.

Cite this

Zundelevich, A., Dadiani, M., Kahana-Edwin, S., Itay, A., Sella, T., Gadot, M., Cesarkas, K., Farage-Barhom, S., Saar, E. G., Eyal, E., Kol, N., Pavlovski, A., Balint-Lahat, N., Dick-Necula, D., Barshack, I., Kaufman, B., & Gal-Yam, E. N. (2020). Erratum: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis (Breast Cancer Research (2020) 22:16 DOI: 10.1186/s13058-020-1246-5). Breast Cancer Research, 22(1), Article 28. https://doi.org/10.1186/s13058-020-01265-y

@article{b08fb8ef936b416997884cf4ca3e8e87,

title = "Erratum: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis (Breast Cancer Research (2020) 22:16 DOI: 10.1186/s13058-020-1246-5)",

abstract = "After the publication of the original article [1], we were notified the upper panel of the Fig. 1, where the patients codes are listed, was cropped by mistake so the patients 1-8 are repeated. The 88 patients should be listed, instead. Below is the correct version of Fig. 1.",

author = "Adi Zundelevich and Maya Dadiani and Smadar Kahana-Edwin and Amit Itay and Tal Sella and Moran Gadot and Karen Cesarkas and Sarit Farage-Barhom and Saar, {Efrat Glick} and Eran Eyal and Nitzan Kol and Anya Pavlovski and Nora Balint-Lahat and Daniela Dick-Necula and Iris Barshack and Bella Kaufman and Gal-Yam, {Einav Nili}",

note = "Publisher Copyright: {\textcopyright} 2020 The Author(s).",

year = "2020",

month = mar,

day = "12",

doi = "10.1186/s13058-020-01265-y",

language = "אנגלית",

volume = "22",

journal = "Breast Cancer Research",

issn = "1465-5411",

publisher = "BioMed Central Ltd.",

number = "1",

}

Zundelevich, A, Dadiani, M, Kahana-Edwin, S, Itay, A, Sella, T, Gadot, M, Cesarkas, K, Farage-Barhom, S, Saar, EG, Eyal, E, Kol, N, Pavlovski, A, Balint-Lahat, N, Dick-Necula, D, Barshack, I , Kaufman, B & Gal-Yam, EN 2020, 'Erratum: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis (Breast Cancer Research (2020) 22:16 DOI: 10.1186/s13058-020-1246-5)', Breast Cancer Research, vol. 22, no. 1, 28. https://doi.org/10.1186/s13058-020-01265-y

Erratum: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis (Breast Cancer Research (2020) 22:16 DOI: 10.1186/s13058-020-1246-5). / Zundelevich, Adi; Dadiani, Maya; Kahana-Edwin, Smadar et al.
In: Breast Cancer Research, Vol. 22, No. 1, 28, 12.03.2020.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum

T2 - ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis (Breast Cancer Research (2020) 22:16 DOI: 10.1186/s13058-020-1246-5)

AU - Zundelevich, Adi

AU - Dadiani, Maya

AU - Kahana-Edwin, Smadar

AU - Itay, Amit

AU - Sella, Tal

AU - Gadot, Moran

AU - Cesarkas, Karen

AU - Farage-Barhom, Sarit

AU - Saar, Efrat Glick

AU - Eyal, Eran

AU - Kol, Nitzan

AU - Pavlovski, Anya

AU - Balint-Lahat, Nora

AU - Dick-Necula, Daniela

AU - Barshack, Iris

AU - Kaufman, Bella

AU - Gal-Yam, Einav Nili

PY - 2020/3/12

Y1 - 2020/3/12

N2 - After the publication of the original article [1], we were notified the upper panel of the Fig. 1, where the patients codes are listed, was cropped by mistake so the patients 1-8 are repeated. The 88 patients should be listed, instead. Below is the correct version of Fig. 1.

AB - After the publication of the original article [1], we were notified the upper panel of the Fig. 1, where the patients codes are listed, was cropped by mistake so the patients 1-8 are repeated. The 88 patients should be listed, instead. Below is the correct version of Fig. 1.

UR - http://www.scopus.com/inward/record.url?scp=85081786564&partnerID=8YFLogxK

U2 - 10.1186/s13058-020-01265-y

DO - 10.1186/s13058-020-01265-y

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 32164744

AN - SCOPUS:85081786564

SN - 1465-5411

VL - 22

JO - Breast Cancer Research

JF - Breast Cancer Research

IS - 1

M1 - 28

ER -

Zundelevich A, Dadiani M, Kahana-Edwin S, Itay A, Sella T, Gadot M et al. Erratum: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis (Breast Cancer Research (2020) 22:16 DOI: 10.1186/s13058-020-1246-5). Breast Cancer Research. 2020 Mar 12;22(1):28. doi: 10.1186/s13058-020-01265-y

Erratum: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis (Breast Cancer Research (2020) 22:16 DOI: 10.1186/s13058-020-1246-5)

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this